Last reviewed · How we verify

NCT06176742

Comparative Effects of ACBT and Bubble Positive Expiratory Pressure Device in Asthmatic Patients

Status unknown NA Last updated 20 December 2023
What this trial tests

NA trial testing Active Cycle Breathing Technique in Asthma in 42 participants. Status unknown.

Timeline
1 September 2023
Primary endpoint
1 January 2024
1 February 2024

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment42
Start date1 September 2023
Primary completion1 January 2024
Estimated completion1 February 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 31 to 40, any sex, with Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study gap is that in previous studies the effects of bubble-PEP in different diseases have been studied but it's never been studied in asthmatic patients, so the reason behind this study is to see effects of bubble-PEP in Asthmatic Patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Asthma

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06176742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing